Annual CFI
-$25.18 M
+$7.16 M+22.13%
December 31, 2023
Summary
- As of February 8, 2025, MLTX annual cash flow from investing activities is -$25.18 million, with the most recent change of +$7.16 million (+22.13%) on December 31, 2023.
- MLTX annual CFI is now at all-time high.
Performance
MLTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$58.28 M
+$146.02 M+166.42%
September 30, 2024
Summary
- As of February 8, 2025, MLTX quarterly cash flow from investing activities is $58.28 million, with the most recent change of +$146.02 million (+166.42%) on September 30, 2024.
- Over the past year, MLTX quarterly CFI has increased by +$146.02 million (+166.42%).
- MLTX quarterly CFI is now -50.13% below its all-time high of $116.87 million, reached on December 31, 2023.
Performance
MLTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$58.60 M
+$232.66 M+133.67%
September 30, 2024
Summary
- As of February 8, 2025, MLTX TTM cash flow from investing activities is $58.60 million, with the most recent change of +$232.66 million (+133.67%) on September 30, 2024.
- Over the past year, MLTX TTM CFI has increased by +$232.66 million (+133.67%).
- MLTX TTM CFI is now at all-time high.
Performance
MLTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MLTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.1% | +166.4% | +133.7% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MLTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.1% | -50.1% | +133.4% | at high | +133.7% |
| 5 y | 5-year | at high | +22.1% | -50.1% | +133.4% | at high | +133.7% |
| alltime | all time | at high | +22.1% | -50.1% | +133.4% | at high | +133.7% |
MoonLake Immunotherapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $58.28 M(-166.4%) | $58.60 M(-133.7%) |
| Jun 2024 | - | -$87.74 M(+204.6%) | -$174.06 M(+136.4%) |
| Mar 2024 | - | -$28.80 M(-124.6%) | -$73.64 M(+192.4%) |
| Dec 2023 | -$25.18 M | $116.87 M(-167.0%) | -$25.18 M(-80.9%) |
| Sep 2023 | - | -$174.38 M(-1475.6%) | -$132.15 M(<-9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $12.68 M(-35.5%) | $0.00(-100.0%) |
| Mar 2023 | - | $19.65 M(+98.4%) | -$12.68 M(-60.8%) |
| Dec 2022 | -$32.34 M | $9.90 M(-123.4%) | -$32.34 M(-23.4%) |
| Sep 2022 | - | -$42.23 M(<-9900.0%) | -$42.24 M(>+9900.0%) |
| Jun 2022 | - | $0.00(-100.0%) | -$16.00 K(0.0%) |
| Mar 2022 | - | -$16.00 K | -$16.00 K |
FAQ
- What is MoonLake Immunotherapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual CFI year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly CFI year-on-year change?
- What is MoonLake Immunotherapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM CFI year-on-year change?
What is MoonLake Immunotherapeutics annual cash flow from investing activities?
The current annual CFI of MLTX is -$25.18 M
What is the all time high annual CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash flow from investing activities is -$25.18 M
What is MoonLake Immunotherapeutics annual CFI year-on-year change?
Over the past year, MLTX annual cash flow from investing activities has changed by +$7.16 M (+22.13%)
What is MoonLake Immunotherapeutics quarterly cash flow from investing activities?
The current quarterly CFI of MLTX is $58.28 M
What is the all time high quarterly CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash flow from investing activities is $116.87 M
What is MoonLake Immunotherapeutics quarterly CFI year-on-year change?
Over the past year, MLTX quarterly cash flow from investing activities has changed by +$146.02 M (+166.42%)
What is MoonLake Immunotherapeutics TTM cash flow from investing activities?
The current TTM CFI of MLTX is $58.60 M
What is the all time high TTM CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM cash flow from investing activities is $58.60 M
What is MoonLake Immunotherapeutics TTM CFI year-on-year change?
Over the past year, MLTX TTM cash flow from investing activities has changed by +$232.66 M (+133.67%)